Cargando…
Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report
BACKGROUND: Nephrotic syndrome causes severe hypercholesterolaemia due to increased production and altered clearance of lipoproteins from the liver. It is challenging for patients with nephrotic syndrome and coronary heart disease to meet LDL-cholesterol (LDL-C) goals for secondary prevention with c...
Autores principales: | Sjuls, Simon, Jensen, Ulf, Littmann, Karin, Bruchfeld, Annette, Brinck, Jonas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189300/ https://www.ncbi.nlm.nih.gov/pubmed/34124564 http://dx.doi.org/10.1093/ehjcr/ytab151 |
Ejemplares similares
-
Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case report
por: Littmann, Karin, et al.
Publicado: (2020) -
Repetitive catamenial myocardial infarction due to coronary artery spasm: a case report
por: Talmor, Nina, et al.
Publicado: (2023) -
A case report of myocardial infarction with non-obstructive coronary arteries as the initial presentation of eosinophilic granulomatosis with polyangiitis
por: Chatta, Payush, et al.
Publicado: (2022) -
Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis
por: Burkert, Francesco Robert, et al.
Publicado: (2021) -
Unsuspected diabetic ketoacidosis after myocardial infarction in a patient treated with SGLT2 inhibitor increased length of stay in the hospital: how can it be prevented? A case report
por: Oriot, Philippe, et al.
Publicado: (2023)